[
  {
    "criterion": "Starts the note with the patient's information, demographics, and medical number.",
    "points": 10,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Includes a subjective section that describes the patient's obstetric history, current symptoms related to preeclampsia (e.g., headache, visual changes, epigastric pain), their onset and duration, any available home blood pressure readings, and whether there is a history of chronic hypertension or kidney disease.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Summarizes the objective findings by documenting vital signs, including elevated blood pressure readings and other baseline measures, and conducts a focused physical exam assessing for signs of distress, neurologic changes, edema, respiratory status, abdominal tenderness, and cardiovascular findings relevant to preeclampsia evaluation.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Summarizes ACOG 2023 criteria for preeclampsia with severe features, including BP ≥160/110 mm Hg on two readings 4 hours apart, severe RUQ or epigastric pain, neurologic or visual disturbances, pulmonary edema, platelet count <100,000/µL, liver enzymes (AST/ALT) ≥2× normal, serum creatinine >1.1 mg/dL or doubled, and evidence of hemolysis if HELLP is suspected.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Summarizes that the initial evaluation for suspected preeclampsia with severe features per ACOG 2023 includes CBC with platelets, LFTs (AST, ALT ± LDH), serum creatinine, hemolysis labs (LDH, bilirubin, haptoglobin if indicated), and coagulation studies when needed, alongside proteinuria assessment via spot protein/creatinine ratio ≥0.3 or 24-hour protein ≥300 mg, and fetal evaluation with NST, BPP, and ultrasound for growth and amniotic fluid.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Includes an assessment part that identifies the working diagnosis as suspected preeclampsia with severe features, based on elevated blood pressure readings (≥160/110 mm Hg) and the presence of additional severe features such as right upper quadrant pain, severe headache, visual disturbances, or abnormal laboratory findings.",
    "points": 4,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Includes a plan with continued blood pressure monitoring and IV antihypertensives if BP remains ≥160/110, ordering of labs and proteinuria assessment, administration of IV magnesium sulfate for seizure prophylaxis, symptom management, fetal assessment with NST or BPP, consultation with OB/MFM, and admission for close monitoring, with delivery timing based on maternal and fetal status.",
    "points": 4,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Explains that for coding preeclampsia with severe features, the correct ICD-10-CM code should reflect the trimester: use O14.1.",
    "points": 4,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Provides outdated recommendations or incorrect data and numbers, such as blood pressure thresholds for diagnosis that are lower or higher than the actual recommendations.",
    "points": -8,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  }
]